Cargando…

Metabolic Impacts of Discontinuation and Resumption of Recombinant Human Growth Hormone Treatment during the Transition Period in Patients with Childhood-Onset Growth Hormone Deficiency

BACKGROUND: Discontinuing growth hormone (GH) treatment during the transition to adulthood has been associated with adverse health outcomes in patients with childhood-onset growth hormone deficiency (CO-GHD). This study investigated the metabolic changes associated with interrupting GH treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yun Jeong, Choi, Yunha, Yoo, Han-Wook, Lee, Young Ah, Shin, Choong Ho, Choi, Han Saem, Kim, Ho-Seong, Kim, Jae Hyun, Moon, Jung Eun, Ko, Cheol Woo, Ahn, Moon Bae, Suh, Byung-Kyu, Choi, Jin-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081298/ https://www.ncbi.nlm.nih.gov/pubmed/35504604 http://dx.doi.org/10.3803/EnM.2021.1384

Ejemplares similares

MON-113 The Effect of Body Mass Index on the Peak Growth Hormone Level After Growth Hormone Stimulation Test in Children with Short Stature
por: Lee, Nayeong, et al.
Publicado: (2020)

Short-term effect of growth hormone treatment in childhood leukemia survivors with growth hormone deficiency
por: Shin, Chungwoo, et al.
Publicado: (2023)

Efficacy of growth hormone therapy in adults with childhood-onset growth hormone deficiency
por: Kim, Ja Hye, et al.
Publicado: (2014)

Recombinant growth hormone therapy in children with Turner Syndrome in Korea: a phase III Randomized Trial
por: Kim, Jinsup, et al.
Publicado: (2021)

SUN-259 Recombinant Growth Hormone Therapy for Children with Turner Syndrome in Korea: A Phase III Randomized Trial
por: Kim, Jinsup, et al.
Publicado: (2019)

Growth without growth hormone in combined pituitary hormone deficiency caused by pituitary stalk interruption syndrome
por: Lee, Sang Soo, et al.
Publicado: (2017)

Design of the long-term observational cohort study with recombinant human growth hormone in Korean children: LG Growth Study
por: Chung, Sochung, et al.
Publicado: (2018)

Predicting First-Year Growth in Response to Growth Hormone Treatment in Prepubertal Korean Children with Idiopathic Growth Hormone Deficiency: Analysis of Data from the LG Growth Study Database
por: Cho, Won Kyoung, et al.
Publicado: (2020)

Effect of body mass index on peak growth hormone level after growth hormone stimulation test in children with short stature
por: Lee, Na Yeong, et al.
Publicado: (2021)

Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome
por: Jeong, Insook, et al.
Publicado: (2016)

Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial
por: Yang, Aram, et al.
Publicado: (2019)

Efficacy and safety of the recombinant human growth hormone in short children born small for gestational age: A randomized, multicentre, comparative phase III trial
por: Kim, Su Jin, et al.
Publicado: (2021)

Efficacy and Safety of Sustained-Release Recombinant Human Growth Hormone in Korean Adults with Growth Hormone Deficiency
por: Kim, Youngsook, et al.
Publicado: (2014)

Sex Hormone-Binding Globulin Is Associated with Obesity and Dyslipidemia in Prepubertal Children
por: Park, Gihong, et al.
Publicado: (2020)

Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG Growth Study
por: Rhie, Young-Jun, et al.
Publicado: (2019)

Influence of Body Mass Index on the Growth Hormone Response to Provocative Testing in Short Children without Growth Hormone Deficiency
por: Lee, Jieun, et al.
Publicado: (2013)

THU167 Trends Of Recombinant Human Growth Hormone Treatment In Korea: Data From The Health Insurance Review And Assessment Service 2015-2020
por: Kim, Jaehyun, et al.
Publicado: (2023)

Rare Frequency of Mutations in Pituitary Transcription Factor Genes in Combined Pituitary Hormone or Isolated Growth Hormone Deficiencies in Korea
por: Choi, Jin-Ho, et al.
Publicado: (2017)

Discriminatory performance of insulin-like growth factor 1 and insulin-like growth factor binding protein-3 by correlating values to chronological age, bone age, and pubertal status for diagnosis of isolated growth hormone deficiency
por: Choi, Yu jung, et al.
Publicado: (2020)

SAT-090 Factors Affecting IGF-1 Level and Correlation with Growth Response During Growth Hormone Treatment in LGS Patients
por: Kim, Jihyun, et al.
Publicado: (2020)

Growth hormone treatment and risk of malignancy
por: Chae, Hyun-Wook, et al.
Publicado: (2015)

Propofol Requirement in Patients with Growth Hormone-Secreting Pituitary Tumors Undergoing Transsphenoidal Surgery
por: Kim, Seung Hyun, et al.
Publicado: (2019)

Efficacy of Short-Term Growth Hormone Treatment in Prepubertal Children with Idiopathic Short Stature
por: Kim, Ho-Seong, et al.
Publicado: (2014)

SAT-102 Height Improvement with Recombinant Human Growth Hormone Therapy at Terminal Stage of Growth
por: Kim, Dae Hyun, et al.
Publicado: (2020)

Factors affecting IGF-I level and correlation with growth response during growth hormone treatment in LG Growth Study
por: Kim, Ji Hyun, et al.
Publicado: (2021)

SAT-303 Combined Treatment of Gonadotropin Releasing Hormone Agonist and Recombinant Human Growth Hormone in Cental Precocious Puberty Patient with Underlying Leri Weill Dyschondrosteosis
por: Choi, Ju-hee, et al.
Publicado: (2019)

Effect of the Orally Active Growth Hormone Secretagogue MK-677 on Somatic Growth in Rats
por: Lee, Junghun, et al.
Publicado: (2018)

Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency
por: Lim, Han Hyuk, et al.
Publicado: (2010)

Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
por: Jung, Mo Kyung, et al.
Publicado: (2014)

MON-243 The Difference of Body Mass Index Score before and after Gonadotropin-Releasing Hormone Agonist Treatment in Cerntral Precocious Puberty Girls
por: Choi, Yujung, et al.
Publicado: (2019)

Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease
por: Jin, Hye-Young, et al.
Publicado: (2021)

Metabolic profiling of cholesterol and sex steroid hormones to monitor urological diseases
por: Moon, Ju-Yeon, et al.
Publicado: (2016)

Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency
por: Lim, Han Hyuk, et al.
Publicado: (2022)

Complete Solubilization and Purification of Recombinant Human Growth Hormone Produced in Escherichia coli
por: Kim, Min-Ji, et al.
Publicado: (2013)

Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
por: Hou, Ling, et al.
Publicado: (2015)

Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 Gene mutation
por: Kim, Yoo-Mi, et al.
Publicado: (2013)

Medullary Thyroid Carcinoma with Ectopic Adrenocorticotropic Hormone Syndrome
por: Choi, Hong Seok, et al.
Publicado: (2014)

High level expression and purification of recombinant flounder growth hormone in E. coli
por: Choi, Tae-Jin, et al.
Publicado: (2018)

Structural and functional characterization of recombinant human growth hormone isolated from transgenic pig milk
por: Lee, So-Young, et al.
Publicado: (2020)

Using Growth Hormone Levels to Detect Macroadenoma in Patients with Acromegaly
por: Park, Ji Young, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_riusrmnj470js5p9a8jedu17ul